MedPath

Fibrostenotic Eosinophilic Esophagitis: Assessment Tools

Recruiting
Conditions
Eosinophilic Esophagitis
Registration Number
NCT02453126
Lead Sponsor
University of Colorado, Denver
Brief Summary

This protocol addresses a central hypothesis that fibrostenotic Eosinophilic Esophagitis (EoE) is characterized by abnormal esophageal structure and compliance compared to non fibrostenotic EoE and that distinctive cellular and molecular profiles predict the fibrostenotic phenotype. This study aims to define and assess the changes that occur in the structure and dynamics of the esophageal wall in pediatric Eosinophilic Esophagitis along with characterizing the histologic and molecular patterns in fibrostenotic EoE.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
250
Inclusion Criteria
  • Scheduled to undergo a clinical upper endoscopy with biopsy
Exclusion Criteria
  • Known connective tissue disorder
  • Increased risk of bleeding
  • Inflammatory bowel disease, celiac disease, eosinophilic gastroenteritis, or any autoimmune disease
  • Other esophageal disease including known achalasia; history of caustic ingestion, esophageal surgery esophageal stricture for other known reason or other esophageal injury.
  • Use of oral or intravenous steroids in the preceding 60 days. (Swallowed topical fluticasone, budesonide, etc not included as exclusion criteria.)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Stricture, as measured by endoscopic assessmentDay 1
Secondary Outcome Measures
NameTimeMethod
Decreased esophageal distensibility, as determined by EndoFlipDay 1

Trial Locations

Locations (1)

Children's Hospital Colorado

🇺🇸

Aurora, Colorado, United States

Children's Hospital Colorado
🇺🇸Aurora, Colorado, United States
Cassandra Burger
Contact
720-777-5739
cassandra.burger@childrenscolorado.org

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.